by developing and commercialising innovative cannabis products.
Cape Sativa has started the development of cannabis based pharmaceutical products, some of which are about to enter human trials for the treatments of infectious diseases including COVID and the treatment of long COVID. Cape Sativa has also advanced the development of treatments for melanoma and non-melanoma skin, cervical and ovarian cancer. We see pharmaceutical application leading to the development of at least 20 block buster applications over the next 5 years.
Cannabis will target under explored therapeutic pathways, the endocannabinoid system.
Cannabis will extend therapeutic options for patients with various diseases.